Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial

Ron Brazg, Satish K. Garg, Anuj Bhargava, James R. Thrasher, Kashif Latif, Bruce W. Bode, Timothy S. Bailey, Barry S. Horowitz, Arvind Cavale, Yogish C. Kudva, Kevin B. Kaiserman, George Grunberger, John Chip Reed, Sarnath Chattaraj, Gina Zhang, John Shin, Vivian Chen, Scott W. Lee, Toni L. Cordero, Andrew S. RhinehartRobert A. Vigersky, Bruce A. Buckingham

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)535-543
Number of pages9
JournalDiabetes Technology and Therapeutics
Volume24
Issue number8
DOIs
StatePublished - Aug 1 2022

ASJC Scopus Subject Areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Keywords

  • Adults
  • Failure rate
  • Insulin infusion set
  • Survival rate
  • Time in range
  • Unexplained hyperglycemia

Cite this